Artwork

Content provided by Ketamine Wellness Centers. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ketamine Wellness Centers or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Does Spravato require patients to be prescribed an antidepressant?

10:42
 
Share
 

Manage episode 229677530 series 1756689
Content provided by Ketamine Wellness Centers. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ketamine Wellness Centers or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
As the P.R. machine kicks into gear to support the launch of Spravato/Esketamine, the first FDA approved Ketamine-derived treatment, Kevin Nicholson (President, CEO of Ketamine Wellness Centers) digs into the details that tend to receive less attention. This episode is about Treatment Resistant Depression and the requirements of Spravato, as such. We touch on: - The clinical definition of Treatment Resistant Depression - What to do about co-occurring conditions such as anxiety, suicidal ideation, ocd, etc? - Does Spravato require patients to be prescribed to an antidepressant to qualify for using it? - Is Spravato utilizing the full potential of Ketamine to treat Depression?
  continue reading

15 episodes

Artwork
iconShare
 
Manage episode 229677530 series 1756689
Content provided by Ketamine Wellness Centers. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ketamine Wellness Centers or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
As the P.R. machine kicks into gear to support the launch of Spravato/Esketamine, the first FDA approved Ketamine-derived treatment, Kevin Nicholson (President, CEO of Ketamine Wellness Centers) digs into the details that tend to receive less attention. This episode is about Treatment Resistant Depression and the requirements of Spravato, as such. We touch on: - The clinical definition of Treatment Resistant Depression - What to do about co-occurring conditions such as anxiety, suicidal ideation, ocd, etc? - Does Spravato require patients to be prescribed to an antidepressant to qualify for using it? - Is Spravato utilizing the full potential of Ketamine to treat Depression?
  continue reading

15 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide